1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Menopause Market, by Treatment
6.1. Introduction
6.2. Dietary Supplements
6.3. OTC Pharma Products
6.3.1. Hormonal products
6.3.2. Non-hormonal products

7. Menopause Market, by Distribution Challenge
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Stores
7.4. Retail Pharmacies

8. California Menopause Market

9. Florida Menopause Market

10. Illinois Menopause Market

11. New York Menopause Market

12. Ohio Menopause Market

13. Pennsylvania Menopause Market

14. Texas Menopause Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Abbvie Inc.
16.2. Allergan plc
16.3. Bayer AG
16.4. Cipla Inc.
16.5. Eli Lilly and Company
16.6. Emcure Pharmaceuticals Ltd.
16.7. GlaxoSmithKline plc
16.8. Glenmark Pharmaceuticals Ltd.
16.9. Hisamitsu Pharmaceutical Co. Inc.
16.10. Merck & Co.Inc.
16.11. Novartis AG
16.12. Novo Nordisk A/S
16.13. Pfizer Inc.
16.14. Teva Pharmaceutical Industries Ltd.
16.15. TherapeuticsMD Inc.

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES MENOPAUSE MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES MENOPAUSE MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2027
FIGURE 6. UNITED STATES MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2020 VS 2027 (%)
FIGURE 15. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2020 VS 2027 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2027
FIGURE 17. UNITED STATES MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES MENOPAUSE MARKET SIZE, BY ONLINE STORES, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES MENOPAUSE MARKET SIZE, BY ONLINE STORES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES MENOPAUSE MARKET: FPNV POSITIONING MATRIX
FIGURE 24. UNITED STATES MENOPAUSE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 25. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES MENOPAUSE MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES MENOPAUSE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES MENOPAUSE MARKET SIZE, BY ONLINE STORES, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES MENOPAUSE MARKET: SCORES
TABLE 13. UNITED STATES MENOPAUSE MARKET: BUSINESS STRATEGY
TABLE 14. UNITED STATES MENOPAUSE MARKET: PRODUCT SATISFACTION
TABLE 15. UNITED STATES MENOPAUSE MARKET: RANKING
TABLE 16. UNITED STATES MENOPAUSE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 17. UNITED STATES MENOPAUSE MARKET: MERGER & ACQUISITION
TABLE 18. UNITED STATES MENOPAUSE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 19. UNITED STATES MENOPAUSE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 20. UNITED STATES MENOPAUSE MARKET: INVESTMENT & FUNDING
TABLE 21. UNITED STATES MENOPAUSE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 22. UNITED STATES MENOPAUSE MARKET: LICENSE & PRICING

Companies Mentioned

Abbvie Inc.
Allergan plc
Bayer AG
Cipla Inc.
Eli Lilly and Company
Emcure Pharmaceuticals Ltd.
GlaxoSmithKline plc
Glenmark Pharmaceuticals Ltd.
Hisamitsu Pharmaceutical Co. Inc.
Merck & Co.Inc.
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
TherapeuticsMD Inc.